Welcome to our dedicated page for Horizon Techn news (Ticker: HRZN), a resource for investors and traders seeking the latest updates and insights on Horizon Techn stock.
Horizon Techn (HRZN) provides venture lending and structured debt solutions to innovation-driven companies across technology, life sciences, healthcare, and related sectors. This news hub offers investors and stakeholders timely access to official updates and strategic developments.
Track all essential HRZN announcements in one location, including earnings reports, partnership agreements, and operational milestones. Our curated collection ensures you stay informed about financing initiatives, portfolio company progress, and industry leadership developments without market speculation.
Key updates cover debt financing arrangements, warrant-related activity, and sector-specific growth initiatives. Bookmark this page for efficient monitoring of Horizon Techn's strategic positioning within specialty finance markets. Regular visits provide critical insights for informed analysis of HRZN's market role and investment profile.
Soli Organic has launched its USDA-certified organic 'Indolce' basil in over 2,000 stores across the Mid-Atlantic region, including major retailers like Walmart and Whole Foods. The new line promises to be priced nearly a dollar less per ounce than field-grown organic produce. Bolstering its operations, the company secured $50 million in venture debt financing from Horizon Technology Finance and Bridge Bank to enhance its production capacity. This follows a previous $120 million financing arrangement, aiming for 15 indoor farms nationwide to meet rising demand for organic produce.
Horizon Technology Finance Management has announced the addition of six professionals to its operations, legal, and investment teams to support growth driven by over $650 million in assets under management (AUM). This expansion aligns with Horizon's commitment to enhancing service for its portfolio companies and improving returns for investors. The new team members bring extensive experience from various financial and legal backgrounds, positioned across Horizon's offices in Farmington, Connecticut, and Pleasanton, California.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced monthly cash distributions of $0.10 per share for July, August, and September 2022, totaling $0.30 per share. The company has paid $182 million in distributions since its IPO in 2010. The Ex-Dividend Dates for the upcoming distributions are June 16, July 18, and August 17, 2022. Horizon also offers a Dividend Reinvestment Plan (DRIP) for shareholders who prefer automatic reinvestment of their distributions into additional shares.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced a 36% year-over-year growth in its investment portfolio, reaching $515 million. The company reported first quarter 2022 net investment income (NII) of $5.7 million, or $0.26 per share, down from $6.0 million a year ago. As of March 31, 2022, HRZN had a net asset value (NAV) of $280 million, or $11.68 per share. With a robust debt portfolio yield of 12.4% and a record committed backlog of $172 million, HRZN is well-positioned for future growth. Monthly distributions of $0.30 per share were declared for July, August, and September.
Horizon Technology Finance Corporation (NASDAQ: HRZN) has successfully closed a venture loan facility with Native Microbials, a company specializing in microbial solutions for animal health. The funding aims to enhance Native Microbials’ manufacturing capabilities, supply chain, and customer services. Horizon's President, Gerald Michaud, highlighted the significant market opportunity in animal health and nutrition supported by Native Microbials' innovative technology. The loan will enable Native Microbials to meet growing demand among farmers and pet owners.
Horizon Technology Finance Corporation (NASDAQ: HRZN) will release its financial results for Q1 2022 after market close on May 3, 2022. A conference call is scheduled for May 4, 2022, at 9:00 a.m. ET, featuring key executives including CEO Robert D. Pomeroy, Jr. Investors can join the call by dialing (877) 407-9716 (domestic) or (201) 493-6779 (international). The call will also be available via a live webcast on the company's website.
Horizon focuses on providing secured loans to venture capital-backed companies in technology, life sciences, and sustainability.
Horizon Technology Finance Corporation (NASDAQ: HRZN) reported a strong Q1 2022, originating $132 million in new loans, with $73 million specifically from HRZN. The company ended the quarter with a record $172 million committed backlog, including $151 million in HRZN commitments. Notably, HRZN also received $12 million in loan prepayments, validating its pricing strategy. The ongoing growth trajectory indicates HRZN's favorable positioning in the specialty finance sector.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced a $15 million venture loan facility to MyForest Foods Co., funding $7.5 million each from Horizon and a managed private investment vehicle. MyForest Foods specializes in sustainable, whole-cut meat alternatives using mycelium, with the flagship product being MyBacon. The funding aims to support MyForest Foods' growth and working capital, as the company seeks to innovate in the alternative foods market. Horizon's President expressed confidence in MyForest Foods' market potential, highlighting the significance of their unique offerings.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced that Chairman and CEO Robert D. Pomeroy, Jr. will engage in a fireside chat at the Maxim Group and M-Vest 2022 Virtual Growth Conference on March 30, 2022, at 3:00 p.m. ET. This event aims to showcase insights into the company, which specializes in securing loans for venture-backed firms in technology, life sciences, and sustainability sectors. Interested participants can register for free at the conference's official site.
On March 17, 2022, Horizon Technology Finance Corporation (NASDAQ: HRZN) announced the closure of a $15 million venture loan facility to Secure Transfusion Services, Inc. Horizon funded $5 million of the initial $10 million draw. STS, which operates blood collection centers, aims to modernize the transfusion supply chain and improve blood component availability. The funding is intended for general growth. Horizon's President highlighted STS's potential in addressing the demand for blood platelets.
FAQ
What is the current stock price of Horizon Techn (HRZN)?
What is the market cap of Horizon Techn (HRZN)?
